| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 5149 | 6-O-Tosyloxyethyl-CBT |
5149.0002: 2 mg per vial
Please inquire for customized filling and bulk quantities. 
|
|
Precursor for [18F]-labeling of N-terminal cysteine-bearing peptides and proteines
|
||
| Molar Mass: 374.44 | ||
| C17H14N2O4S2 | ||
| [1392498-16-6] | ||
| Colourless to yellowish solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: 2-Benzothiazolecarbonitrile, 6-[2-[[(4-methylphenyl)sulfonyl]oxy]ethoxy]- |
||
|
Synonymes: 2-(2-cyanobenzothiazol-6-yloxy) 4-methylbenzenesulfonate; TE-CBT |
||
|
Literature: Ren H. et al. A biocompatible condensation reaction for the labeling of terminal cysteine residues on proteins. Angew. Chem. Int. Ed. 2009, 48, 9658-9662. |
||
| Jeon J. et al. Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine. Bioconjugate Chem. 2012 , 23, 1902 - 1908. | ||
| Godinat A. et al. A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice. ACS Chem. Biol. 2013, 8, 987-999. | ||
| date of product catalogue issue: 10 May 2017 | ||